Humana, CVS battle for Cano Health: We unpack why the two companies are going after primary care disruptor Cano, and posit which player might have the upper hand.
Smartwatches and fitness trackers face slump: Rising inflation, economic uncertainty, and slowing innovation are ending pandemic-era hyper-growth as the segment matures.
Meta tries to skirt around ATT: A lawsuit alleges that the social media giant injected tracking code into its in-app browsers, breaking privacy rules.
Nvidia’s new edge AI computing platform highlights the need to protect surgical robots and medical devices from hacking.
Pfizer expands its agreement with CytoReason by five years to boost AI’s role in drug development. We spotlight the trend in the pharma world.
The EHR giant’s new Life Sciences program shows how large datasets can help expand clinical trial access to underserved communities.
Getting DTx apps like Big Health’s Sleepio on formularies mean doctors trust them—something important to ensure patient uptake.
Osmind’s Zoom mental health integrations show how mental health is at the forefront of virtual care.